Dapagliflozin

Function:
On the basis of diet and exercise, this product can be used as a monotherapy to improve blood sugar control in adults with type 2 diabetes. Important limitations of use: This product is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis.

Dosage:
The recommended starting dose of this product is 5 mg, taken once a day in the morning, without food restrictions. For patients who require enhanced glycemic control and tolerate 5 mg once daily, the dose may be increased to 10 mg once daily. In patients who are volume depleted, it is recommended that the condition be corrected before initiating treatment with this product. Patients with renal insufficiency are advised to evaluate renal function before initiating treatment with this product and periodically thereafter. Treatment with this product is not recommended for patients with eGFR lower than 60mL/min/1.73m2. No dose adjustment is required for patients with mild renal insufficiency (eGFR ≥ 60mL/min/1.73m2). If the eGFR range persists from 30 to less than 60mL/min/1.73m2, treatment with this product is not recommended. If the eGFR is lower than 30mL/min/1.73m2, the use of this product is contraindicated. Patients with Hepatic Impairment No dosage adjustment is required in patients with mild, moderate, or severe hepatic impairment. However, the safety and efficacy of this product have not been specifically studied in patients with severe hepatic impairment. Therefore, the benefits and risks of using this product in this population should be assessed separately. The same drug produced by different manufacturers or there are inconsistent instructions. If you find that the contents of the drug instructions are inconsistent before taking the medicine, please consult your doctor or pharmacist in time.

Drug contraindications:
Disabled if allergic to this product
Related dosage forms:
tablet